Jolt Health Inc. (JOLT) | WebDisclosure

Basculer en Français

8295	Companies
114850	Keywords
55292	Articles
62440	Press releases

Home
Companies
Jolt Health Inc.

BRIEF

published on 07/26/2024 at 23:05, 3 months 25 days ago

Jolt Health Inc. annonce une correction des détails de financement

Biotechnologie Investissement Dans La Santé Jolt Santé Mise À Jour Sur Le Financement Correction Du Communiqué De Presse
BRIEF

published on 07/26/2024 at 23:05, 3 months 25 days ago

Jolt Health Inc. Announces Correction in Financing Details

Biotechnology Press Release Correction Healthcare Investment Jolt Health Financing Update
PRESS RELEASE

published on 07/26/2024 at 23:00, 3 months 25 days ago

Jolt Health Inc. Financing Update
Jolt Health Inc. corrects an error in its press release, stating it will issue 83,333,333 units at $0.006 per unit, not 583,333,333 units. The company focuses on healthcare, biotechnology, and artificial intelligence

Biotechnology Healthcare Press Release Correction Jolt Health Inc.
BRIEF

published on 07/25/2024 at 23:05, 3 months 26 days ago

Jolt Health Inc. annonce un financement

Financement Placement Privé Actions Ordinaires Bons De Souscription Fonds De Roulement
BRIEF

published on 07/25/2024 at 23:05, 3 months 26 days ago

Jolt Health Inc. Announces Financing

Private Placement Common Shares Warrants Working Capital Financing
PRESS RELEASE

published on 07/25/2024 at 23:00, 3 months 26 days ago

Jolt Health Inc. Announces Financing
Jolt Health Inc. announces a $500,000 non-brokered private placement offering. The company plans to issue units at $0.006 per unit for working capital. Insiders expected to participate

Private Placement Working Capital Financing Insiders Jolt Health Inc.
BRIEF

published on 06/10/2024 at 22:55, 5 months 10 days ago

Jolt Health Inc. Terminates Acquisition Agreement and Shifts Focus to AI Opportunities

Acquisition Technology AI Healthcare Jolt Health
BRIEF

published on 06/10/2024 at 22:55, 5 months 10 days ago

Jolt Health Inc. met fin à l'accord d'acquisition et se concentre sur les opportunités liées à l'IA

Acquisition Technologie IA Soins De Santé Jolt Santé
PRESS RELEASE

published on 06/10/2024 at 22:50, 5 months 10 days ago

Jolt Health Inc. Terminates Acquisition Agreement and Shifts Focus to AI Opportunities
Jolt Health Inc. terminates acquisition of transdermal delivery technology for chloroquine and hydroxychloroquine, focusing on AI opportunities in healthcare and biotechnology. CEO Gerald Tritt emphasizes value of AI technology and growth initiatives

Biotechnology AI Technology Healthcare Jolt Health Inc. Gerald Tritt
BRIEF

published on 05/06/2024 at 23:30, 6 months 14 days ago

Jolt Health Inc. Acquires Revolutionary HCQ Transdermal Patch Technology

FDA Approval Transdermal Patch Technology Jolt Health Inc. Hydroxychloroquine Biotechnology Assets

Accesswire

Published on 11/21/2024 at 11:30, 34 minutes ago

FireFox Trenching Returns More High-Grade Gold at the Mustajärvi Gold Project in Lapland, Finland
Published on 11/21/2024 at 10:03, 2 hours 1 minute ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 2 hours 4 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 3 hours 4 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 11 hours 29 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 11:30, 34 minutes ago

APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived
Published on 11/21/2024 at 11:01, 1 hour 3 minutes ago

Original-Research: SMT Scharf AG (von Montega AG): Kaufen
Published on 11/21/2024 at 11:00, 1 hour 4 minutes ago

First Patient Treated in Phase I/II Trial in Acute Myeloid and Acute Lymphoblastic Leukemia with Lu177-PentixaTher, Expanding the Evidence Base for Targeted Radiotherapy Approach
Published on 11/21/2024 at 10:56, 1 hour 7 minutes ago

ABO Energy closes sale for two Battery Projects in South Africa
Published on 11/21/2024 at 10:30, 1 hour 34 minutes ago

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024

Les Echos

Published on 11/21/2024 at 06:58, 5 hours 6 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 5 hours 6 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 5 hours 6 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 15 hours 56 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 16 hours 44 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE